Mechanisms of action of CCK to activate central vagal afferent terminals.
about
Odors activate dual pathways, a TRPC2 and a AA-dependent pathway, in mouse vomeronasal neurons.The calcium oscillator of GnRH-1 neurons is developmentally regulatedRole of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons.Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids.Role of cholecystokinin in anorexia induction following oral exposure to the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol, 3-acetyldeoxynivalenol, fusarenon X, and nivalenol.Vagal control of satiety and hormonal regulation of appetiteVagal afferent stimulation activates astrocytes in the nucleus of the solitary tract via AMPA receptors: evidence of an atypical neural-glial interaction in the brainstem.Obesity induces functional astrocytic leptin receptors in hypothalamus.From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance.Incretin hormones and the satiation signal.Pharmacological investigations of the cellular transduction pathways used by cholecystokinin to activate nodose neurons.Nutritional status-dependent endocannabinoid signalling regulates the integration of rat visceral information.Gastric vagal afferent modulation by leptin is influenced by food intake status.Systemic cholecystokinin amplifies vago-vagal reflex responses recorded in vagal motor neurones.Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders.
P2860
Q33840419-462A8E5D-BC87-4EA0-9C2D-9866D2EF7B17Q34121214-5B4B36C6-4C10-4A30-BFCE-040832D79F91Q34197734-44B25377-5485-44B0-814D-7FE2AA9BA7F9Q34229528-60D49FBD-33A7-4F21-93FA-BD3CE96CF098Q34582675-E1395B62-D2C6-4242-8B35-AACF48B8D59EQ35587505-6B5EFC8D-916D-42E6-902A-E5914A68EA41Q36242605-8930B7C9-8756-4F91-AD03-A51802FAE525Q37158192-C6DB4F2A-C4DB-4820-B23F-AE5C857016A7Q37690695-4DF0E773-0BC1-47DB-A0B2-13FD0FF1F856Q37808286-CE5B5374-5688-4A62-805F-B06BAB4B8605Q38072203-26DD1F07-2212-45F6-B8A9-B6D38ACFAA88Q38307066-270B9B87-D62D-47ED-A657-F3628A651F38Q38944697-03B8F006-00C0-4A34-B290-B58A1E072D6AQ44689881-5FA77FDC-7037-4999-AC42-CE613D1696D9Q51364181-770509C9-4A5B-42BA-82C2-C6312601BEFCQ55233736-804AB0F1-61E0-4F67-A2A5-91D5177C1E44
P2860
Mechanisms of action of CCK to activate central vagal afferent terminals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of action of CCK to activate central vagal afferent terminals.
@en
Mechanisms of action of CCK to activate central vagal afferent terminals.
@nl
type
label
Mechanisms of action of CCK to activate central vagal afferent terminals.
@en
Mechanisms of action of CCK to activate central vagal afferent terminals.
@nl
prefLabel
Mechanisms of action of CCK to activate central vagal afferent terminals.
@en
Mechanisms of action of CCK to activate central vagal afferent terminals.
@nl
P2860
P1433
P1476
Mechanisms of action of CCK to activate central vagal afferent terminals.
@en
P2093
Gerlinda E Hermann
Richard C Rogers
P2860
P304
P356
10.1016/J.PEPTIDES.2008.06.023
P577
2008-07-04T00:00:00Z